Global Automated Cannabis Testing Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Chromatography Based Analyzer, and Spectroscopy Based Analyzer), By Application (Pain Management, Seizures, Sclerosis, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035.

Global Automated Cannabis Testing Market Insights Forecasts to 2035

• The Global Automated Cannabis Testing Market Size Was Estimated at USD 1.52 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 11.45% from 2025 to 2035
• The Worldwide Automated Cannabis Testing Market Size is Expected to Reach USD 5.01 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

The global automated cannabis testing market size was worth around USD 1.52 billion in 2024 and is predicted to grow to around USD 5.01 billion by 2035 with a compound annual growth rate (CAGR) of 11.45% from 2025 and 2035. The market for automated cannabis testing offers opportunities for increasing regulatory compliance, increasing test accuracy, growing medical cannabis applications, incorporating cutting-edge technologies, and satisfying the growing demand for safe, high-quality cannabis products worldwide in the pharmaceutical and healthcare industries.  

Market Overview

The industry devoted to offering cutting-edge technology and tools for automated cannabis sample analysis is known as the automated cannabis testing market. This market includes tools, software, and services made to improve cannabis testing procedures' precision, effectiveness, and compliance with regulations. The primary purpose of these systems is to identify potency, impurities, leftover solvents, and other important characteristics in cannabis products intended for both medical and recreational use. The levels of cannabinoids, terpenes, pesticides, heavy metals, moisture content, etc., can be quickly and more accurately determined with the automated cannabis testing market.

Growing public knowledge of the advantages of cannabis for pain relief and other medical uses will further open up potential opportunities for the global automated cannabis testing market. Increasing demand for high-quality medicinal cannabis products, legalization of marijuana in different parts of the world, the spread of contemporary technologies in cannabis testing labs, and the rise in R&D labs are some of the key factors driving the automated cannabis testing market.

Report Coverage

This research report categorizes the automated cannabis testing market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the automated cannabis testing market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the automated cannabis testing market. 

Driving Factors

Growing government legalizations of medical marijuana distribution and use are also contributing to the automated cannabis testing market. One of the main factors driving the expansion of automated cannabis testing is the growing use of automation in this process. The market for automated cannabis testing is anticipated to develop as a result of the growing number of medical cannabis clubs and increased knowledge of the health advantages associated with cannabis use. Growing legalization, stricter quality standards, and the increasing need for scalable laboratory automation are the main factors propelling the market.

Restraining Factors

The market for automated cannabis testing is restricted by a number of factors, such as the high cost of equipment, the absence of standardized testing procedures, intricate regulatory frameworks, a shortage of skilled labor, and uneven legalization laws in different jurisdictions, all of which prevent broad adoption and market growth.

Market Segmentation

The automated cannabis testing market share is classified into product type and application.

• The chromatography based analyzer segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast perio

Based on the product type, the automated cannabis testing market is divided into chromatography based analyzer and spectroscopy based analyzer. Among these, the chromatography based analyzer segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The great sensitivity and accuracy of chromatography techniques in detecting cannabis, terpenes, pesticides, and other pollutants is what drives the chromatography-based analyzer market. Chromatography-based analyzers are essential to cannabis quality assurance due to their speed and accuracy in performing comprehensive chemical profiling.

• The pain management segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the automated cannabis testing market is divided into pain management, seizures, sclerosis, and others. Among these, the pain management segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The growing use of medical cannabis as an alternative therapy for chronic pain and associated disorders is propelling the pain management market. In pain management, precise cannabinoid profile and contaminant identification are essential for guaranteeing both product effectiveness and patient safety.  

Regional Segment Analysis of the Automated Cannabis Testing Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the automated cannabis testing market over the predicted timeframe.

North America is anticipated to hold the largest share of the automated cannabis testing market over the predicted timeframe. The North American region can be attributed to the following factors: the legalization of cannabis in some regions, the growing popularity of cannabis for pain management applications, the existence of major market participants, and rising research expenditures. Growing research and development efforts to investigate the possible advantages of cannabis, as well as an increase in the number of cannabis testing labs and the increasing use of automation, will also create new growth opportunities in the automated cannabis testing market in North America.

Asia Pacific is expected to grow at a rapid CAGR in the automated cannabis testing market during the forecast period. Asia-Pacific's market is expanding rapidly due to factors like industrialization, urbanization, and a tech-savvy populace. Cost-effective manufacturing, growing digital infrastructure, and rising foreign investments are the main drivers of China, Japan, South Korea, and India's contributions. The need for cutting-edge solutions in consumer goods, technology, automobiles, and energy is also growing in the region.  

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the automated cannabis testing market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Todaro robotics
• PerkinElmer Inc.
• Hamilton Company
• Quantum Analytics
• Agilent Technologies, Inc.
• Medicinal Genomics Corp
• Shimadzu Scientific Instruments
• Others  

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the automated cannabis testing market based on the below-mentioned segments:  

Global Automated Cannabis Testing Market, By Product Type

• Chromatography Based Analyzer
• Spectroscopy Based Analyzer

Global Automated Cannabis Testing Market, By Application  

• Pain Management
• Seizures
• Sclerosis
• Others

Global Automated Cannabis Testing Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa